Prostate-specific TAAs such as Prostate-Specific Antigen (PSA) and Prostatic Acid Phosphatase (PAP) may be loaded onto DCs encoded in mRNA to boost anti-tumor cell immune recognition (118). This evidence concerns the gene ACP3 and neoplasm.